Aptamer-Based Nongenetic Reprogramming of CARs Enables Flexible Modulation of T Cell-Mediated Tumor Immunotherapy.
Zhang Q, Wu L, Zhang Y, Wang D, Sima Y, Wang Z, Yin Z, Wu H, Zhuo Y, Zhang Y, Wang L, Chen Y, Liu Y, Qiu L, Tan W.
Zhang Q, et al. Among authors: zhuo y.
ACS Cent Sci. 2024 Mar 21;10(4):813-822. doi: 10.1021/acscentsci.3c01511. eCollection 2024 Apr 24.
ACS Cent Sci. 2024.
PMID: 38680567
Free PMC article.